The effectiveness of group cognitive behavioral therapy on resilience,functional anxiety,and symptom severity in patients with irritable bowel syndrome

Abstract

Introduction:

Irritable Bowel Syndrome (IBS) is a prevalent digestive disorder characterized by abdominal pain and changes in bowel movements without any structural disorders. The present study aims to explore the impact of group Cognitive Behavioral Therapy (CBT) on resilience, functional anxiety, and the severity of IBS symptoms in patients from Hamadan, Iran.

Methods:

This study employed a semi-experimental, pre-test-post-test design with a control group. The participants were patients diagnosed with IBS referred to the gastroenterology clinic at Ibn Sina Hospital in Hamedan, Iran. A total of 40 patients were selected through simple random sampling and divided into experimental and control groups. The intervention consisted of CBT, based on the framework by Leahy et al. To measure the outcomes, this study used the Connor-Davidson Resilience Scale (CD-RISC) (2003), the Zung Self-Rating Anxiety Scale (SAS) (1970), and the Irritable Bowel Syndrome Severity Score (IBSSS). After completing the intervention, this research administered a post-test to both groups using the same questionnaires.

Results:

The study utilized multivariate and univariate covariance analyses to examine the data and test the research hypotheses. The results revealed that group CBT sessions led to notable differences between the experimental and control groups. Specifically, the subjects in the experimental group showed a significant reduction in functional anxiety, a decrease in the severity of IBS, and an increase in resilience compared to the control group.

Conclusion:

The results indicate that group CBT significantly reduces functional anxiety and the severity of IBS symptoms while boosting resilience.

Keywords

Cognitive behavioral therapy resilience functional anxiety severity of irritable bowel syndrome symptoms

Get full access to this article

View all access options for this article.

References

Sibelli

Chalder

Everitt

, et al. Positive and negative affect mediate the bidirectional relationship between emotional processing and symptom severity and impact in irritable bowel syndrome. J Psychosom Res 2018; 105: 1–13. https://doi.org/10.1016/j.jpsychores.2017.11.016

De Gucht

. Illness perceptions mediate the relationship between bowel symptom severity and health-related quality of life in IBS patients. Qual Life Res 2015; 24(8): 1845–1856. https://doi.org/10.1007/s11136-015-0932-8

Goodoory

Khasawneh

Thakur

, et al. Effect of brain-gut behavioral treatments on abdominal pain in irritable bowel syndrome: systematic review and network meta-analysis. Gastroenterology 2024; 167(5): 934–943. e5. https://doi.org/10.1053/j.gastro.2024.05.010

Staudacher

Black

Teasdale

, et al. Irritable bowel syndrome and mental health comorbidity—approach to multidisciplinary management. Nat Rev Gastroenterol Hepatol 2023; 20(9): 582–596. https://doi.org/10.1038/s41575-023-00794-z

Black

Ford

. Global burden of irritable bowel syndrome: trends, predictions and risk factors. Nat Rev Gastroenterol Hepatol 2020; 17(8): 473–486. https://doi.org/10.1038/s41575-020-0286-8

Gao

Lee

Zhang

, et al. Ocular nociception and neuropathic pain initiated by blue light stress in C57BL/6J mice. Pain 2023; 164(7): 1616–1626. https://doi.org/10.1097/j.pain.0000000000002896

Babakhanzadeh

Ahteshamzadeh

Eftekharsaadi

, et al. The effectivenss of metacognitve therapy with emphasis for brain executive functions on cognitive-attentional syndrom and sense of coherence in anxious persons. Couns Culture Psycother 2019; 10(38): 195–220. https://doi.org/10.22054/qccpc.2019.40298.2080

Keshavarz

Rafei

Mirzae

. The effectiveness of acceptance and commitment therapy (ACT) on general anxiety. Payesh 2018; 17(3): 289–296.

Staudacher

Mikocka-Walus

Ford

. Common mental disorders in irritable bowel syndrome: pathophysiology, management, and considerations for future randomised controlled trials. Lancet Gastroenterol Hepatol 2021; 6(5): 401–410. https://doi.org/10.1016/S2468-1253(20)30363-0

10.

Masaeli

Kheirabadi

Afshar

, et al. Relationship between quality of life and symptom severity in patients with irritable bowel syndrome. Gastroenterol Clin Biol 2004; 28(1): 11–15.

11.

Francis

Morris

Whorwell

. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther 1997; 11(2): 395–402. https://doi.org/10.1046/j.1365-2036.1997.142318000.x

12.

Ford

Lacy

Talley

. Irritable bowel syndrome. N Engl J Med 2017; 376(26): 2566–2578. https://doi.org/10.1056/NEJMra1607547

13.

Lee

Mahurkar-Joshi

Naliboff

, et al. Role of sex, anxiety, and resilience in the association between adverse childhood experiences and irritable bowel syndrome. Clin Gastroenterol Hepatol 2025; 23(1): 154–162.e2. https://doi.org/10.1016/j.cgh.2024.05.041

14.

Lackner

Jaccard

Keefer

, et al. Improvement in gastrointestinal symptoms after cognitive behavior therapy for refractory irritable bowel syndrome. Gastroenterology 2018; 155(1): 47–57. https://doi.org/10.1053/j.gastro.2018.03.063

15.

Park

Naliboff

Shih

, et al. Resilience is decreased in irritable bowel syndrome and associated with symptoms and cortisol response. Neurogastroenterol Motil 2018; 30(1): e13155. https://doi.org/10.1111/nmo.13155

16.

Everitt

Landau

O’Reilly

, et al. Assessing telephone-delivered cognitive–behavioural therapy (CBT) and web-delivered CBT versus treatment as usual in irritable bowel syndrome (ACTIB): a multicentre randomised trial. Gut 2019; 68(9): 1613–1623. https://doi.org/10.1136/gutjnl-2018-317805

17.

Chey

Keefer

Whelan

, et al. Behavioral and diet therapies in integrated care for patients with irritable bowel syndrome. Gastroenterology 2021; 160(1): 47–62. https://doi.org/10.1053/j.gastro.2020.06.099

18.

Lackner

Jaccard

Radziwon

, et al. Durability and decay of treatment benefit of cognitive behavioral therapy for irritable bowel syndrome: 12-month follow-up. Am J Gastroenterol 2019; 114(2): 330–338. https://doi.org/10.1038/s41395-018-0396-x

19.

Connor

Davidson

. Development of a new resilience scale: the Connor-Davidson resilience scale (CD-RISC). Depress Anxiety 2003; 18(2): 76–82.

20.

Samani

Joukar

Sahragard

. Effects of resilience on mental health and life satisfaction. Iran J Psychiatry Clin Psychol 2007; 13: 290–295. https://doi.org/10.1002/da.10113

21.

Zung

. A rating instrument for anxiety disorders. Psychosomatics 1971; 12: 371–379. https://doi.org/10.1016/S0033-3182(71)71479-0

22.

Montazeri

Vahdaninia

Ebrahimi

, et al. The Hospital Anxiety and Depression Scale (HADS): translation and validation study of the Iranian version. Health Qual Life Outcomes 2003; 1(1): 14. https://doi.org/10.1186/1477-7525-1-14

23.

Solati dehkordy

Adibi

Ghamarani

. The effects of cognitive– behavior therapy and drug therapy on quality of life and symptoms of patients with irritable bowel syndrome. J Kerman Univ Med Sci 2012; 19(1): 94–103.

24.

Leahy

Holland

McGinn

. Treatment plans and interventions for depression and anxiety disorders. New York: Guilford Press, 2011.

25.

Aliyari Khanshan Vatan

Ahadi

, et al. Comparison of the effectiveness of cognitive behavioral therapy and emotion-oriented therapy on physical self-concept and distress tolerance of women with coronary heart disease. Rooyesh-e-Ravanshenasi Journal (RRJ) 2023; 12(9): 117–128.

26.

Jacobs

Gupta

Bhatt

, et al. Cognitive behavioral therapy for irritable bowel syndrome induces bidirectional alterations in the brain-gut-microbiome axis associated with gastrointestinal symptom improvement. Microbiome 2021; 9(1): 236.

27.

Slouha

Patel

Mohamed

, et al. Psychotherapy for irritable bowel syndrome: a systematic review. Cureus 2023; 15(12): e51003.